Tuesday, October 7, 2025 | 12:30-1:30 pm | 238 Strom Thurmond Institute
Along with our scheduled Advanced RCR events, we will also host this upcoming webinar on October 7th at 12:30 pm in 238 Strom Thurmond Institute. This will count as one hour of advanced RCR credit. If interested in attending, please email rcrtraining@clemson.edu to RSVP by October 5th.
NABR Webinar: “From Promise to Practice: The Current Landscape of New Approach Methodologies”
Please join the Office of Research Compliance for Dr. Szczepan Baran’s presentation titled “From Promise to Practice: The Current Landscape of New Approach Methodologies”. An abundance of viewpoints have been in the news and on social media surrounding the FDA announcement on April 10, about their Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs; the NIH announcement creating the Office of Research Innovation, Validation, and Application (ORIVA) later on the same month; and the July 7 announcement by the Acting Deputy Director of the Division of Program Coordination, Planning and Strategic Initiatives (DPCPSI) within the NIH Office of the Director that “all new NIH-funded opportunities moving forward should incorporate language on consideration of NAMS” and “The NIH will no longer seek proposals exclusively for animal models.”
We have invited a special guest speaker to help us understand what all this means as pressure mounts to modernize biomedical research. New Approach Methodologies (NAMs) including in vitro, in silico, and human-relevant models — are gaining visibility as alternatives to traditional animal studies. But visibility does not always equate to implementation. This presentation will offer a high-level yet practical overview of where we stand today with NAMs: which technologies are maturing, which are overhyped, and where policy, infrastructure, and culture must evolve to enable true transformation. Drawing from experiences across regulatory science, industry, and academia, Dr. Szczepan Baran will explore what it takes to bridge scientific innovation with real-world impact — ethically, efficiently, and collaboratively.